Related Experiment Video
Updated: Aug 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Psyllium in hypercholesterolemia
1School of Pharmacy, University of California, San Francisco 94143, USA.
Psyllium fiber can modestly lower LDL cholesterol, but is not a substitute for statin drugs. It serves as a beneficial dietary supplement for individuals with mild hypercholesterolemia, particularly when combined with diet therapy.
Area of Science:
- Cardiovascular Health
- Nutritional Science
- Pharmacology
Background:
- Hypercholesterolemia poses a significant risk for coronary events.
- Dietary interventions are primary for managing high cholesterol.
- Conventional lipid-lowering drugs have substantial effects but potential side effects.
Purpose of the Study:
- To evaluate the efficacy of psyllium in lowering cholesterol levels.
- To compare psyllium's lipid-lowering effects with conventional antilipidemic agents.
- To determine psyllium's role as an adjunct therapy in hypercholesterolemia management.
Main Methods:
- Controlled study evaluating psyllium's impact on total and LDL cholesterol.
- Comparison of psyllium's effects against lovastatin.
- Assessment of psyllium's tolerability and compliance.
Main Results:
- Psyllium demonstrated a 4-8% reduction in total cholesterol and 6-13% in LDL cholesterol.
- These effects are minimal compared to lovastatin (30% total cholesterol, 40% LDL cholesterol reduction).
- Psyllium is well-tolerated with minor transient side effects and high compliance (>90%).
Conclusions:
- Psyllium is not recommended as drug therapy for moderate-to-severe hypercholesterolemia.
- Psyllium can be a useful adjunct to AHA step 1 diet therapy for low-risk individuals.
- Further research is needed on psyllium's effects in women and long-term efficacy.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cholecystitis

